This inventor holds 8 USPTO granted patents and 3 EPO patents. Top assignees: Meda Pharmaceuticals Inc., Medpointe Healthcare Inc.. Active years: 2002-2018.
Company Filing History:
Years Active: 2002-2018
Title: Innovations by Alexander D D'Addio
Introduction
Alexander D D'Addio is a notable inventor based in Piscataway, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions that improve the delivery and efficacy of azelastine. With a total of 8 patents to his name, D'Addio's work has had a meaningful impact on treating various allergic conditions.
Latest Patents
D'Addio's latest patents focus on pharmaceutical compositions comprising azelastine, including its salts and esters. These inventions provide methods to enhance the effectiveness of azelastine while minimizing unpleasant side effects, such as post-nasal drip and bitter taste. The compositions are designed to treat or prevent disorders like allergic rhinitis and allergic conjunctivitis, offering symptomatic relief to patients. The use of effective excipients, such as hypromellose and sucralose, plays a crucial role in these formulations.
Career Highlights
Throughout his career, D'Addio has worked with prominent companies in the pharmaceutical industry, including Meda Pharmaceuticals Inc. and Medpointe Healthcare Inc. His experience in these organizations has allowed him to refine his expertise in drug formulation and development.
Collaborations
D'Addio has collaborated with talented professionals in his field, including Gul Balwani and Phuong Grace Dang. These partnerships have contributed to the advancement of his innovative work and the successful development of his patented compositions.
Conclusion
Alexander D D'Addio's contributions to pharmaceutical innovations demonstrate his commitment to improving patient care through effective treatments. His patents reflect a deep understanding of drug formulation and the importance of addressing side effects in therapeutic compositions.